Authors


Sibylle Scholtz, PhD

Latest:

Evolution of optical coherence tomography of the human eye

Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.


Ainhoa Molina-Martín, PhD

Latest:

The relationship between myopia and conjunctival-scleral geometry

Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.


Steven Silverstein, MD

Latest:

Intracanalicular insert linked to reduced hyperemia and itching

As dexamethasone adds indications, a study confirms efficacy of punctal occlusion for allergic conjunctivitis.


Terri-Diann Pickering, MD

Latest:

EDITORIAL: Déjà vu all over again

When it comes to the sexes in the operating room, the key is collaboration, with a goal of presenting patient suffering.


Lisa Stewart, PhD

Latest:

Dietary supplement can improve measurable visual outcomes

Higher levels of 3 macular pigments minimize risk of age-related disease.


Jennifer I. Lim, Md, FARVO, FASRS

Latest:

Considerations for the Future of Biosimilars in the Treatment of Retinal Disorders

Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.


Jesse Richman, MD

Latest:

Combination drops may help patients challenged by multiple glaucoma meds

Drops can simplify dosing, improving adherence and ocular surface health


Nicole Fram, MD

Latest:

IOL Selection for Eyes With Unique Anatomy

Nicole Fram, MD concludes this series on the potential of decentration and subsequent IOLs misalignment, highlighting zero and negative spherical aberration lens options for these unique cases.


Charles Wykoff, MD, PHD

Latest:

Unmet Needs and the Future of Wet AMD Care

Expert panelists provide an overview of current unmet needs in wet AMD care and discuss the potential for improving clinical outcomes and treatment burden.



Ashley Behrens, MD

Latest:

Looking to the future of cataract surgery

In recognition of Cataract Awareness Month.


John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA

Latest:

IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.


Akash Maheshwari, MBA

Latest:

Being an ophthalmologist on an airplane: Tips in the event of a medical emergency during a flight

Andrew G. Lee, MD, has had direct experience as being an in-flight physician over 15 times on international and domestic flights and answers some of the most frequently asked questions about being the doctor on the plane.


Tianyi Wang

Latest:

Bridging the gap: Real World Ophthalmology connects young ophthalmologists with invaluable knowledge and expertise

RWO is hosting its 5th virtual, interactive conference titled “Top 10 Things I Wish I Knew Sooner” on Saturday September 30, 2023, from 8 am to 5:30 pm Central Time.


David Wirta, MD

Latest:

Dry eye renaissance: Escalating cases meet with innovation

For clinicians, the evolution of treatment is as much a responsibility as an opportunity.


H. Burkhard Dick, MD, PhD

Latest:

Zeroing in on standalone glaucoma treatment options

Steps to take when a patient does not have a cataract.


Rahul S. Tonk, MD, MBA

Latest:

Eye Care Products in the Pipeline for Dry Eye Disease

Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.


Alcina Lidder, MD

Latest:

Blog: TAGS trial and real life applications

Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.


David J. Calkins, PhD
David J. Calkins, PhD

Latest:

Restoring vision in glaucoma: more than meets the eye

New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.


Puja Laroia

Latest:

Adding tools and techniques to your skillset: Real World Ophthalmology

Enhance your ophthalmology skills with expert tips from RWO podcast. Match procedures to patients, seek guidance, review surgical notes, practice patience, and be honest with patients.


Brad Sifrig, MD

Latest:

Standardizing terminology for clarity in refractive surgery

Language can drive understanding, trust, and better outcomes for patients


Maximilian J. Gerhardt, MD

Latest:

Will experience support use of first-ever retinal gene therapy?

Recent reports of retinal atrophy have raised concerns on potential long-term safety.


Jordana Joy

Latest:

Aurion Biotech doses first Canadian patient in Phase 1/2 ABA-1, CLARA clinical trial of AURN001

The 1-time, intracameral injection is a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction.


Helia Ashourizadeh, MD

Latest:

Managing a sticky situation: Real World Ophthalmology

Corneal wound burn is a critical, yet often overlooked, complication in cataract surgery. Recognizing early signs is crucial.


Steven H. Dewey, MD

Latest:

Seven pearls for a more stable chamber

Staying current on phaco technology can help surgeons provide better outcomes.


Brett H. Mueller, II, DO, PhD

Latest:

For younger patients with midrange myopia, consider phakic IOLs

The implantable lenses can offer an advantage over laser surgery.


Patrick Campbell

Latest:

Systematic review suggests vitamin D deficiency doubles risk of noninfectious uveitis

Patients considered vitamin D deficient had a risk of noninfectious uveitis more than twice that of their counterparts without vitamin D deficiency.



Martin David Harp

Latest:

Aldeyra Therapeutics outlines clinical development plan for resubmission of reproxalap NDA

Following the CRL from the FDA last year, Aldeyra is planning to initiate a dry eye chamber clinical trial in the first half of 2024.


Glaucoma Research Foundation

Latest:

Glaucoma + nutrition: why what you eat matters

There’s no shortage of diet programs—Paleo, Mediterranean, intermittent fasting—all claiming to be the best option for a healthy life. Research has shown that poor lifestyle choices, including unhealthy diets, contribute to many diseases and that simply adhering to good nutrition can even prevent some health issues.

© 2024 MJH Life Sciences

All rights reserved.